CNS Drugs (journal)
| Discipline | Drug therapy, pharmacology |
|---|---|
| Language | English |
| Edited by | Kate Palmer and Sue Pochon |
| Publication details | |
| History | 1994-present |
| Publisher | Adis International (Springer Nature) (New Zealand) |
| Frequency | Monthly |
| Hybrid | |
| 5.749 (2020) | |
| Standard abbreviations | |
| ISO 4 | CNS Drugs |
| Indexing | |
| ISSN | 1172-7047 (print) 1179-1934 (web) |
| OCLC no. | 477236411 |
| Links | |
CNS Drugs is a monthly peer-reviewed medical journal published by Adis International (Springer Nature) that covers drug treatment of psychiatric and neurological disorders.
Abstracting and indexing
[edit]The journal is abstracted and indexed in:
- MEDLINE
- EMBASE
- International Pharmaceutical Abstracts
- BIOSIS Previews
- Current Contents/Clinical Medicine
- Current Contents/Life Sciences
- Science Citation Index
- Neuroscience Citation Index
- PASCAL
- Chemical Abstracts Service
- PsycINFO
According to the Journal Citation Reports, the journal has a 2023 impact factor of 7.4.[1]
References
[edit]- ^ "InCites Journal Citation Reports". apps.clarivate.com. Retrieved 2018-09-10.
External links
[edit]
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |